turps the info' I read appears to be a poster at a pain conference however I would imagine the coy would be busy working on an oxymorphone paper where the reviewers would believe the results could be replicated . If this comes to pass the oxym' patch could indeed be an attractive proposition to potential partners . The esoterics of technical development !!
- Forums
- ASX - By Stock
- Ann: FDA meeting provides guidance for TPM/Oxymorphone patch
turps the info' I read appears to be a poster at a pain...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add POH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
POH (ASX) Chart |
Day chart unavailable